用甲状腺蛋白-阿尔法对差异化甲状腺癌的PET成像
Grayson R Gimblet1, Pratheek Reddy1, Michelle M Holland2
1Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Scientific reports
|April 2, 2025
概括
这项研究评估了[89Zr]Zr-thyrotropin-alfa,一种针对甲状腺刺激激素受体 (TSHR) 的新型PET放射性药物. 该药物在TSHR表达细胞和异种移植中显示出高吸收率,支持其临床试验的潜力.
科学领域:
- 核医学是一种核医学.
- 放射性药物开发的发展.
- 在瘤学瘤学.
背景情况:
- 甲状腺素-阿尔法是一种FDA批准的复合人类TSH激动剂.
- 甲状腺刺激激素受体 (TSHR) 是诊断和治疗应用的潜在目标.
研究的目的:
- 在临床前模型中,评估甲状腺增生蛋白-阿尔法作为一种针对TSHR的PET放射性药物,[89Zr]Zr-甲状腺增生蛋白-阿尔法.
- 评估[89Zr]Zr-thyrotropin-alfa用于TSHR向成像的体外和体内性能.
主要方法:
- 通过将p-SCN-Bn-deferoxamine (DFO) 与thyrotropin-alfa结合并用89Zr进行放射性标记,合成[89Zr]Zr-thyrotropin-alfa.
- 在实验室中使用TSHR表达和野生类型细胞进行细胞吸收研究.
- 在携带TSHR表达异位移植的小鼠中进行了体内PET成像和体外生物分布研究.
主要成果:
- [89Zr]Zr-thyrotropin-alfa在TSHR+细胞中的体外摄取量明显高于野生类型细胞.
- 阻断研究证实了[89Zr]Zr-thyrotropin-alfa对TSHR的特异性.
- 在体内PET成像和体外生物分布显示,TSHR+异种移植在雄性和雌性小鼠中的优先吸收.
结论:
- [89Zr]Zr-thyrotropin-alfa是一种有前途的TSHR向PET放射性药物,在TSHR表达细胞和瘤中具有特定的吸收.
- 这些临床前发现支持进一步优化和对[89Zr]Zr-thyrotropin-alfa的潜在临床研究.
更多相关视频
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
467
相关概念视频
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
56
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
56
01:29Positron Emission Tomography
3.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
3.9K
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
74
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
74